1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31659
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPerram, Jacinta-
dc.contributor.authorPurtill, Duncan-
dc.contributor.authorBajel, Ashish-
dc.contributor.authorButler, Jason-
dc.contributor.authorO'Brien, Tracey-
dc.contributor.authorThe, Benjamin-
dc.contributor.authorGilroy, Nicole-
dc.contributor.authorHo, Phoebe J-
dc.contributor.authorDoocey, Richard-
dc.contributor.authorHills, Thomas-
dc.contributor.authorPerera, Travis-
dc.contributor.authorDouglas, Genevieve-
dc.contributor.authorRamachadran, Shanti-
dc.contributor.authorChee, Lynette-
dc.contributor.authorTrotman, Judith-
dc.contributor.authorWeinkove, Robert-
dc.contributor.authorKeogh, Steven-
dc.contributor.authorFraser, Chris-
dc.contributor.authorCochrane, Tara-
dc.contributor.authorWatson, Anne-Marie-
dc.contributor.authorDiamond, Peter-
dc.contributor.authorLatimer, Maya-
dc.contributor.authorIrving, Ian-
dc.contributor.authorBlyth, Emily-
dc.contributor.authorCheah, Chan-
dc.contributor.authorCole, Theresa-
dc.contributor.authorMilliken, Sam-
dc.contributor.authorYang, Hung-
dc.contributor.authorGreenwood, Matthew-
dc.contributor.authorBardy, Peter-
dc.contributor.authorKennedy, Glen-
dc.contributor.authorLarsen, Stephen-
dc.contributor.authorConyers, Rachel-
dc.contributor.authorHamad, Nada-
dc.date2023-
dc.date.accessioned2023-01-12T01:59:54Z-
dc.date.available2023-01-12T01:59:54Z-
dc.date.issued2023-
dc.identifier.citationInternal Medicine Journal 2023; 53(1)en_US
dc.identifier.issn1445-5994-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31659-
dc.description.abstractPatients post haematopoietic stem cell transplant or CAR-T cell therapy face significant risk of morbidity and mortality from SARS-CoV19, due to their immunosuppressed state. As case numbers in Australia and New Zealand continue to rise, guidance on management in this high-risk population is needed. Whilst we have learnt much from international colleagues who faced high infection rates early in the pandemic, guidance relevant to local health system structures, medication availability and emerging therapies is essential to equip physicians to optimally manage our patients. This article is protected by copyright. All rights reserved.en_US
dc.language.isoeng-
dc.titleANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternal Medicine Journalen_US
dc.identifier.affiliationHaematology Department, Westmead Hospital, NSW, Australia.en_US
dc.identifier.affiliationFiona Stanley Hospital, WA, Australia.en_US
dc.identifier.affiliationClinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, VIC, Australia.en_US
dc.identifier.affiliationRoyal Brisbane and Women's Hospital, QLD, Australia.en_US
dc.identifier.affiliationSydney Children's Hospital, NSW, Australia.en_US
dc.identifier.affiliationNational Centre for Infections in Cancer and Department of Infectious Diseases, Peter MacCallum Cancer Institute, VIC, Australia.en_US
dc.identifier.affiliationCentre for Infectious Diseases and Microbiology, Westmead Hospital, NSW, Australia.en_US
dc.identifier.affiliationRoyal Prince Alfred Hospital and the University of Sydney, NSW, Australia.en_US
dc.identifier.affiliationAuckland City Hospital, Auckland, New Zealand.en_US
dc.identifier.affiliationWellington Blood and Cancer Centre, Wellington, New Zealand.en_US
dc.identifier.affiliationAustin Hospital, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, WA, Australia.en_US
dc.identifier.affiliationClinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, VIC, Australia.en_US
dc.identifier.affiliationConcord Repatriation General Hospital and University of Sydney.en_US
dc.identifier.affiliationWellington Blood & Cancer Centre and Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.en_US
dc.identifier.affiliationUniversity of Sydney and Westmead Hospital, NSW, Australia.en_US
dc.identifier.affiliationChildren's Health Queensland Hospital and Health Service, QLD, Australia.en_US
dc.identifier.affiliationGold Coast University Hospital, QLD, Australia.en_US
dc.identifier.affiliationLiverpool Hospital, NSW, Australia.en_US
dc.identifier.affiliationLeukaemia Foundation, NSW, Australia.en_US
dc.identifier.affiliationCanberra Hospital, ACT, Australia.en_US
dc.identifier.affiliationICON Cancer Centre, QLD, Australia.en_US
dc.identifier.affiliationUniversity of Sydney and Westmead Hospital, NSW, Australia.en_US
dc.identifier.affiliationSir Charles Gairdner Hospital, WA, Australia.en_US
dc.identifier.affiliationThe Royal Children's Hospital Melbourne, VIC, Australia.en_US
dc.identifier.affiliationSt Vincent's Hospital Sydney and School of Clinical Medicine, Faculty of Medicine and Health, UNSW, NSW, Australia.en_US
dc.identifier.affiliationAustralian Bone Marrow Donor Registry, NSW, Australia.en_US
dc.identifier.affiliationRoyal North Shore Hospital, NSW, Australia.en_US
dc.identifier.affiliationRoyal Adelaide Hospital, SA, Australia.en_US
dc.identifier.affiliationRoyal Brisbane and Women's Hospital, QLD, Australia.en_US
dc.identifier.affiliationRoyal Prince Alfred Hospital and the University of Sydney, NSW, Australia.en_US
dc.identifier.affiliationThe Royal Children's Hospital Melbourne, VIC, Australia.en_US
dc.identifier.affiliationSt Vincent's Hospital Sydney and School of Clinical Medicine, Faculty of Medicine and Health, UNSW, NSW, Australia.en_US
dc.identifier.affiliationClinical Haematologyen_US
dc.identifier.doi10.1111/imj.15978en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-0054-7906en_US
dc.identifier.orcid0000-0003-0213-5470en_US
dc.identifier.orcid0000-0001-8009-4593en_US
dc.identifier.orcid0000-0002-2668-1399en_US
dc.identifier.orcid0000-0002-3667-2613en_US
dc.identifier.orcid0000-0001-7929-1450en_US
dc.identifier.pubmedid36371767-
local.name.researcherDouglas, Genevieve
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.